120 related articles for article (PubMed ID: 25674716)
21. Personalized lung cancer treatment based on molecular determinants.
Simon GR
J S C Med Assoc; 2011 Oct; 107(5):183-4. PubMed ID: 22057801
[No Abstract] [Full Text] [Related]
22. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
Aggarwal C; Langer CJ
Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
[TBL] [Abstract][Full Text] [Related]
23. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Bunn PA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
[No Abstract] [Full Text] [Related]
24. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy for non-small-cell lung cancer.
Kalemkerian GP
Lancet; 2010 Apr; 375(9722):1230-1. PubMed ID: 20338628
[No Abstract] [Full Text] [Related]
26. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.
Des Guetz G; Uzzan B; Nicolas P; Valeyre D; Sebbane G; Morere JF
Crit Rev Oncol Hematol; 2012 Dec; 84(3):340-9. PubMed ID: 22534083
[TBL] [Abstract][Full Text] [Related]
27. Treatment algorithm in 2014 for advanced non-small cell lung cancer: therapy selection by tumour histology and molecular biology.
Manegold C
Adv Med Sci; 2014 Sep; 59(2):308-13. PubMed ID: 25240504
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of non-small cell lung cancer - where we are?].
Milanowski J; Szmygin-Milanowska K
Pneumonol Alergol Pol; 2013; 81(1):55-60. PubMed ID: 23258472
[TBL] [Abstract][Full Text] [Related]
29. Treatment of recurrent small cell lung cancer.
Davies AM; Evans WK; Mackay JA; Shepherd FA
Hematol Oncol Clin North Am; 2004 Apr; 18(2):387-416. PubMed ID: 15094178
[No Abstract] [Full Text] [Related]
30. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
Sangha R; Lara PN; Mack P; Gandara DR
Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
[No Abstract] [Full Text] [Related]
31. [Clinical advances in the chemotherapy of non-small cell lung cancer].
Liao ML; Cheng BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):480-2. PubMed ID: 15312563
[No Abstract] [Full Text] [Related]
32. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
[No Abstract] [Full Text] [Related]
33. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
Greillier L; Barlesi F
Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
[No Abstract] [Full Text] [Related]
34. [Preoperative chemotherapy in patients with non-small cell lung cancer].
Adachi A; Hayashi A; Hayashida R; Hattori R; Nagamatsu Y; Nasu K; Iwanaga D; Takagi K; Ono H; Kakegawa T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):673-5. PubMed ID: 8385907
[No Abstract] [Full Text] [Related]
35. [Current drug therapy of bronchial cancer].
Drings P
Verh Dtsch Ges Inn Med; 1990; 96():228-41. PubMed ID: 1965460
[No Abstract] [Full Text] [Related]
36. Maintenance therapy in non-small-cell lung cancer.
Stinchcombe TE; West HL
Lancet; 2009 Oct; 374(9699):1398-400. PubMed ID: 19767096
[No Abstract] [Full Text] [Related]
37. Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.
Kanazu M; Maruyama K; Ando M; Asami K; Ishii M; Uehira K; Minomo S; Matsuda Y; Kawaguchi T; Atagi S; Ogawa Y; Kusunoki Y; Takada M; Kubo A
Clin Lung Cancer; 2014 May; 15(3):182-7. PubMed ID: 24518101
[TBL] [Abstract][Full Text] [Related]
38. Combination versus alternating chemotherapy in small-cell lung cancer.
Lai SL; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.
Tarhini A; Kotsakis A; Gooding W; Shuai Y; Petro D; Friedland D; Belani CP; Dacic S; Argiris A
Clin Cancer Res; 2010 Dec; 16(23):5900-7. PubMed ID: 21045083
[TBL] [Abstract][Full Text] [Related]
40. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
Kawahara M
Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
